Nephronophthisis (NPHP) 4 gene coding nephrocystin-4 is involved in the development of renal tubules and its congenital mutations cause juvenile end-stage renal disease, NPHP. To investigate the association between single-point single-nucleotide polymorphism (SNP) of NPHP4 gene and renal function, we conducted a cross-sectional study in Japanese population. The subjects of this study were non-diabetic general population consisting of 2604 individuals 440 years in Takahata town, Japan. We genotyped 11 SNPs within NPHP4 gene that displayed frequent minor allele frequencies (40.1) in Japanese general population. Among 11 SNPs in NPHP4 gene, only rs1287637 that induces amino acid substitution (A (Gln)/T (Leu)), located in the acceptor site of exon 21, showed a significant association with estimated glomerular filtration rate (eGFR; T/T: 81.3 ± 15.6 (n¼1886), A/T: 82.0 ± 15.5 (n¼652) and A/A: 87.4 ± 21.4 ml min À1 per 1.73m 2 (n¼66); mean ± s.d., P¼0.006). This SNP was not in linkage disequilibrium with the surrounding SNPs. The multivariate analysis adjusted with possible confounders showed that the A/T+T/T genotype of rs1287637 was independently associated with reduced renal function (eGFR o90 ml min À1 per 1.73m 2 ; odds ratio (OR) 1.75, 95% confidence interval (CI) 1.05-2.94, P¼0.033). These results indicate the novel and independent association between single-point SNP rs1287637 in NPHP4 gene and renal function in non-diabetic Japanese population.
INTRODUCTION
Familial and genetic studies have revealed that renal function is heritable and the genetic factors seem to have a role in the susceptibility and the progression of various renal diseases. 1, 2 Among them, there are several types of inherited renal diseases that result in poor renal outcome. Nephronophthisis (NPHP), a group of autosomal recessive cystic kidney disorders, is the most common genetic cause of end-stage renal disease in the first three decades of life. 3 The renal histology of NPHP shows interstitial cell infiltration and fibrosis, tubular basement disruption and development of microcysts at the corticomedullary junction. 4 NPHP is a genetically heterogeneous disorder and positional cloning has identified nine genes (NPHP1-9) causing NPHP. 5 Each of NPHP1-9 genes encodes nephrocystin-1, inversin, nephrocystin-3-6, Gli-similar protein, RPGRIP1L protein and NEK8, respectively. The clinical and genetic aspects of NPHP1, the most frequently mutated NPHP gene, has been well documented in NPHP patients. [6] [7] [8] However, the impact of mutation of NPHP genes on renal function in general population is largely unknown. We previously investigated the association between renal function and genotypes of single-nucleotide polymorphisms (SNPs; rs33958626, rs35638834 and rs35367711) in NPHP1 gene and found no significant association between them in general Japanese population.
In current study, we focused on NPHP4, the second major cause of NPHP, and examined whether its genotype has any effect on renal function in non-diabetic population.
MATERIALS AND METHODS

Study population
This study is a part of the ongoing molecular epidemiological study utilizing the regional characteristics of 21st century Centers of Excellence (COE) and global COE Program in Japan, as previously described in detail. 9 The aim of the present study is to determine the association between genetic variants and renal function in the general population in Japan. This study is a design-incorporated baseline survey that consisted of a self-administrated questionnaire on lifestyle, blood pressure measurement, anthropometrical measurement, and collections of blood and urine specimens from participants at annual health checkup. Genomic DNA was extracted from peripheral blood samples to determine the SNPs, as previously described. 10 The survey population in this study is the general population 440 years old in Takahata, Japan. In 2004 and 2005, a total of 3115 subjects (mean age 63; men 1380, women 1735) took part in the program and agreed to join the study. This study was approved by the Institutional Ethical Committee. All participants gave written informed consent.
Among 3115 subjects, 162 and 234 subjects were excluded from the present analysis owing to their incomplete data and having diabetes mellitus, respectively. Furthermore, to avoid the effect of potential renal diseases, we excluded the 115 subjects with increased urine albumin and b2-microglobulin-creatinine excretion. Thus, 2604 subjects were entered into final analyses (mean age 62; men 1156, women 1448).
Measurement
Clinical information regarding medical history, current medication, smoking habits and alcohol intake was obtained from a self-reported questionnaire. Blood pressures were determined by using a mercury manometer in subjects who had rested in a sitting position for at least 5 min before the measurement. Hypertension was defined as systolic blood pressure X140 mm Hg and/or diastolic blood pressure X90 mm Hg, and/or the use of anti-hypertensive medication. Body mass index was calculated from weight and height measures as weight (kg) divided by the square of height (m 2 ). Diabetes was ascertained either by self-reported physical diagnosis or by a measure of fasting blood sugar X126 mg dl À1 or hemoglobin A1c (HbA1c) value X6.5%. Hypercholesterolemia was ascertained by a measure of serum total cholesterol level X220 mg dl À1 , and/or the use of anti-hyperlipidemic medication. Urine albumin concentration was determined using immunoturbidimetry. Urine albumin-creatinine ratio was calculated from a single-spot urine specimen collected in the morning. Urine b2-microglobulin was assessed using the latex agglutination method. Urine b2-microglobulin levels corrected with urine creatinine (urine b2-microglobulin-creatinine ratio (UBCR)) were used for the analyses. It is widely accepted that proteinuria, almost equal to the urine albumin-creatinine ratio levels of 4300 mg g À1 , is a risk for end-stage renal disease. 11 Another study showed that increased urine b2-microglobulin excretion (UBCR 41000 mg g À1 ) was a risk for a higher 10-year mortality due to cardiovascular and renal disease. 12 Based on these reports, to avoid the effect of potential renal diseases, we excluded the subjects with urine albumin-creatinine ratio 4300 mg g À1 or UBCR 41000 mg g À1 in this study. Serum creatinine was measured by enzymatic method and estimated glomerular filtration rate (eGFR) was obtained using the equation modified for Japanese. 13 
SNP selection and genotyping
NPHP4 gene is located on chromosome 1p36.22. We utilized Haploview software version 3.32 (http://www.broadinstitute.org/haploview/haploview) and dbSNP database of the National Center for Biotechnology Information (http://www. ncbi.nlm.nih.gov/SNP/) and International HapMap Project (http://www.hapmap. org/index.html) to extract all SNPs of the NPHP4 gene with a minor allele frequency 40.1 in the Japanese general population. In all, 11 SNPs (rs11121648 in intron 29, rs489933 in intron 26, rs1287626 in intron 23, rs472651 in intron 23, rs905467 in intron 22, rs1287637 in exon 21, rs11121956 in intron 18, rs12058375 in intron 16, rs962662 in intron 11, rs1566724 in intron 9 and rs806104 in intron 2) were selected and have been genotyped. All SNPs gave accurate typing (call rate 499%) and were used in this study.
Genotyping of these 11 SNPs were performed as previously described. 10 Briefly, it was determined by Invader assay (Third Wave Technologies, Madison, WI, USA) 14, 15 and Taqman allelic discrimination assay. 16 Reagents were purchased from Applied Biosystems (Foster City, CA, USA). TaqMan probes were designed and synthesized by Applied Biosystems and it distinguished the SNPs at the end of a PCR. One allelic probe was labeled with fluorescent FAM dye and the order with the fluorescent VIC dye. PCR was performed by TaqMan Universal Master Mix without UNG (Applied Biosystems), with PCR primers at a concentration of 900 nM and TaqMan MGB probes at a concentration of 200 nM. Reactions were performed in 384-well formats in a total reaction volume of 3 ml using 3 ng of genomic DNA. The plates were then placed in a GeneAmp PCR System 9700 (Applied Biosystems) and heated at 95 1C for 10 min, followed by 40 cycles at 92 1C for 15 s and 60 1C for 1 min, with a final soak at 25 1C. The plates were read by the Prism 7900HT instrument (Applied Biosystems) where the fluorescence intensity in each well of the plate was read. 16 Fluorescence data files from each plate were analyzed by the SDS 2 allele calling software (Applied Biosystems). Several data (signal intensity) were eliminated to preserve the reliability of the assay system (missing data are guaranteed to be o1%).
Statistical analyses
We used Student's t-test or an analysis of variance to evaluate the differences in means, and w 2 -tests to evaluate the differences in proportions. Some of the clinical and biochemical traits in each genotypic group did not distribute normally; we applied a non-parametric Mann-Whitney test or Kruskal-Wallis test. To examine the independent association between genotype and renal function, age, gender-adjusted and multivariate logistic regression analyses were performed. In multivariate model, possible confounders including age, gender, drinking, smoking, obesity, hypertension and hypercholesterolemia were adjusted. To confirm Hardy-Weinberg equilibrium among genotypes, w 2 -tests were used (PX0.05). Linkage disequilibrium for the combination of variations was tested by D¢ and r 2 using Haploview. Data are expressed as mean±s.d. except as otherwise indicated. A significant difference was defined as Po0.05. All statistical analyses were performed using SPSS version 15.0.1 J (SPSS, Chicago, IL, USA).
RESULTS
Characteristics of subjects
Baseline characteristics of 2604 subjects who entered into a final analysis were as follows; mean age 62 years, 1156 men (44.4%), 1373 subjects (52.7%) with hypertension, 746 subjects (28.6%) with obesity and 867 subjects (33.3%) with hypercholesterolemia.
Association of single-point SNPs of NPHP4 with eGFR
The chromosomal locations of 11 SNPs of NPHP4 gene selected as in Methods section are shown in Figure 1 and their characteristics are summarized in Table 1 . To investigate whether NPHP4 gene SNPs are associated with renal function, we performed quantitative trait locus analyses using analysis of variance. It showed that only the genotypes of SNP6 rs1287637 was significantly associated with eGFR; the eGFR of T/T, T/A and A/A genotypes were 81.3±15.6, 82.0±15.5 and 87.4±21.4 ml min À1 per 1.73 m 2 , respectively (P¼0.006; Table 2 ).
To examine the linkage disequilibrium of NPHP4 gene, we performed linkage disequilibrium analysis using these 11 SNPs typing data and observed no obvious consistency of genotypes between SNP6 rs1287637 and the other 10 SNPs (Figure 2) . 
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The comparison of clinical parameters between the genotypes of SNP6 rs1287637 Next, we compared the clinical parameters between the genotypes of SNP6 rs1287637. There was no significant difference between them in clinical characters such as age, gender, the levels of blood pressure, body mass index and HbA1c. Neither urine albumin nor b2-microglobulin excretions, the markers of glomerular and tubular damages, showed any statistical difference (Table 3) . We further investigated the prevalence of cyst formation in 343 subjects using the results of renal ultrasonography. The simple cysts were observed in only one subject (11.1%) of A/A group (n¼9) and 43 subjects (12.9%) of A/T+T/T group (n¼334). None of them showed typical polycystic changes observed in NPHP. These results indicate that the difference in eGFR between these genotypes showed no significant association with the comorbidities or cystic formation.
The independent association between the genotypes of SNP6 rs1287637 and reduced renal function To investigate the independent association between the genotypes of SNP6 rs1287637 and renal function, we performed age, gender-adjusted and multivariate logistic regression analyses. In age, gender-adjusted analysis, the rs1287637 A/A+A/T genotype showed a borderline significance with reduced renal function (eGFR o90 ml min À1 per 1.73 m 2 ; OR 1.66, 95% CI 0.99-2.78, P¼0.054). In multivariate logistic regression analysis, the rs1287637 A/A+A/T genotype was independently related to reduced renal function (OR 1.75, 95% CI 1.05-2.94, P¼0.033; Table 4 ).
DISCUSSION
In this study, we have revealed the novel and independent association between the genotypes of SNP rs1287637 in NPHP4 gene and renal function in non-diabetic Japanese population 440 years old. This result indicates that genetic variation of NPHP4 might be involved in the renal function not only in children, but also in the general population.
The renal function gradually declines along with aging. In this studied population, the eGFR values in the majority of subjects were within the predicted range for their age. Furthermore, we excluded the subjects with potential renal diseases in this study. Although the epidemiological setting does not allow us to specify the cause of renal decline individually, these findings suggest that the main reason for reduced renal function is not specific renal diseases, but aging in this population. In the process of renal aging, various factors are involved including hypertension, diabetes, dyslipidaemia, nephrotoxic agents, hormonal changes, lifestyle-related factors such as diet, smoking and drinking, and genetic property. 17 In this study, the subjects Abbreviations: ANOVA, analysis of variance; eGFR, estimated glomerular filtration rate; LSD, Fisher's least significant difference; NCBI, National Center for Biotechnology Information; SNP, singlenucleotide polymorphism.
NPHP4 genotype and renal function T Konta et al with diabetes or potential renal diseases were excluded and the aforementioned possible factors were adjusted, however, we still found the independent association between the NPHP4 genotypes and renal function. Although it is not examined how the eGFR difference between rs1287637 genotypes is affected by aging, there is a possibility that the eGFR difference between these genotypes is attributed, at least in part, to the genetic factor itself. The association of the defects in NPHP gene with premature renal failure has been vigorously investigated in various types of NPHP, 3 however, the interests of the researchers were mainly limited to the effect of gene mutation on renal deterioration in children. Usually, severe renal deterioration due to NPHP4 genetic abnormalities occurs in young generation. 18, 19 Interestingly, this study uncovered that the renal function was associated with NPHP4 variants also in later generations, middle-aged and elderly. The location of SNP6 rs1287637 is further downstream of genetic variations previously reported in NPHP. 19 Taken together, our finding suggests that the genetic variation of rs1287637 might be the novel factor to modulate renal function in non-diabetic Japanese adults.
The nephrocystin-4 encoded by NPHP4 is located in centrosomes in the cilia of renal tubular cells together with other types of nephrocystin and has an important role in regulating urine flow and intracellular calcium concentration. 3 It is speculated that these proteins regulate the dilatation of renal tubules, and the malfunction of these proteins induces the cystic formation. 20 In this study, the comparison of characters between genotypes of rs1287637 showed that this SNP was associated with renal function, with no significant difference in clinical parameters and cyst formation. Furthermore, the multivariate regression analysis showed that the association of the genetic variation of this SNP with renal function was significant after adjustment with known risk factors. These results suggest that the genetic variants of rs1287637 might affect the renal function not via the development of comorbidities or obvious structural changes.
To clarify the precise mechanism of this phenomenon, the experimental study might be required.
Genome-wide analysis suggests the existence of multiple candidate genes related to renal function in general population. 1 Therefore, even though the difference in eGFR caused by single SNP was not so large, it is possible that the accumulated effects of these genetic variations including NPHP4 cause a great influence on renal function in general population.
This study has several limitations. First, there is no information on how the genetic variation of rs1287637 causes the structural and functional changes in nephrocystin-4 protein. This point is beyond the scope of this study and should be clarified in further examination. Second, in this population, the mutation in other NHPH genes except NPHP1 was not investigated. It is reported that NPHP sometimes accompanies simultaneous mutations in different NPHP genes. 21 Although the prevalence of renal abnormalities due to the mutation in other NPHP genes is low, there is a possibility that the difference in eGFR might be caused in part by the interaction between mutations in other NPHP genes.
In conclusion, our study showed the novel and independent association between single-point SNP rs1287637 in NPHP4 gene and renal function. This SNP might be one of genetic factors that affect the renal function in non-diabetic Japanese adults. 
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Block 2 (64 kb) Block 1 (7 kb) 0.9 < r 2 < 1 0.8 < r 2 ≤ ≤ 0.9 Figure 2 The linkage disequilibrium analysis of 11 single-nucleotide polymorphisms (SNPs) of nephronophthisis (NPHP4) gene.
